| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/14/2009 | WO2009018909A3 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 05/14/2009 | WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 05/14/2009 | US20090124671 Trpv1 antagonists |
| 05/14/2009 | US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them |
| 05/14/2009 | US20090124657 Pharmaceutical compositions comprising montelukast |
| 05/14/2009 | US20090124653 Muscarinic Acetylcholine Receptor Antagonists |
| 05/14/2009 | US20090124645 Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels |
| 05/14/2009 | US20090124638 Anti-inflammatory pyrazolopyrimidines |
| 05/14/2009 | US20090124604 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 05/14/2009 | US20090124594 Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases |
| 05/14/2009 | US20090124591 Synthesis and Use of Cationic Steroids for Anti-Inflammatory Drug Therapy |
| 05/14/2009 | US20090124586 Aqueous-based pharmaceutical composition |
| 05/14/2009 | US20090124555 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
| 05/14/2009 | US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 05/14/2009 | US20090123478 Human antibody molecules for IL-13 |
| 05/14/2009 | US20090123422 Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y |
| 05/14/2009 | US20090123391 Novel Formulations |
| 05/14/2009 | US20090123370 Alphavbeta6 peptide ligands and their uses |
| 05/14/2009 | CA2705316A1 Modulation of factor 7 expression |
| 05/14/2009 | CA2705303A1 Modulation of protein trafficking |
| 05/14/2009 | CA2705159A1 Methods for administering corticosteroid formulations |
| 05/14/2009 | CA2704746A1 Use of umbilical cord blood in the treatment of premature birth complications |
| 05/14/2009 | CA2703996A1 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/14/2009 | CA2703987A1 Cyclobutyl carboxylic acid derivatives |
| 05/14/2009 | CA2703511A1 Crystalline hydrate of betamimetika and use as medicament thereof |
| 05/13/2009 | EP2058332A1 Use of CD25 binding molecules in steroid-resistant patients |
| 05/13/2009 | EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 05/13/2009 | EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 05/13/2009 | EP2058293A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 05/13/2009 | EP2057152A1 Single enantiomer beta-agonists, methods for the production thereof and the use thereof as medication |
| 05/13/2009 | EP2057134A1 Single enantiomer beta agonists method for production and use thereof as a medicament |
| 05/13/2009 | EP2057122A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor |
| 05/13/2009 | EP2056837A1 Aerosol formulation for the inhalation of beta-agonists |
| 05/13/2009 | EP2056836A1 Powder formulations for inhalation containing enantiomerically pure beta-agonists |
| 05/13/2009 | EP2056805A1 Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1711485B1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1062209B1 Metabolically inert anti-inflammatory and anti-tumor antifolates |
| 05/13/2009 | CN101432009A Preventative treatment and remission of allergic diseases |
| 05/13/2009 | CN101432002A Method and composition for treating chronic obstructive pulmonary disease |
| 05/13/2009 | CN101431993A Use of DHA and ARA in the preparation of a composition for regulating gene expression |
| 05/13/2009 | CN101431991A Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness |
| 05/13/2009 | CN101429254A Bletilla striata polysaccharide, preparation method and new uses thereof |
| 05/13/2009 | CN101428134A Process for producing four-Tibet inula root soft capsule |
| 05/13/2009 | CN101428075A Biological agent for preventing and treating respiratory passage diseases of livestock and poultry |
| 05/13/2009 | CN101428049A Upper respiratory tract infection resistant medicament composition, preparation and uses thereof |
| 05/13/2009 | CN101428044A Novel broad spectrum antiphlogistic pain-easing medicament for treating multiple oral diseases |
| 05/13/2009 | CN101428041A Cordyceps sinensis extract, preparation method and uses in preparing medicament |
| 05/13/2009 | CN101428011A Inhalation powder spray for treating respiratory diseases such as chronic obstructive pulmonary disease and asthma |
| 05/13/2009 | CN101428010A Process for producing salbutamol sulfate fine powder |
| 05/13/2009 | CN101427993A Prostaglandin microemulsion gel rubber preparation and method of producing the same |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/13/2009 | CN100486646C Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy |
| 05/13/2009 | CN100486642C 疫苗 Vaccine |
| 05/13/2009 | CN100486616C Aerosol and its preparation method |
| 05/13/2009 | CN100486612C Soft capsule containing Bupleurum and Radix scutellariae, preparation method and use thereof |
| 05/13/2009 | CN100486608C Coryza-treating capsule and preparation process thereof |
| 05/13/2009 | CN100486597C A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof |
| 05/13/2009 | CN100486594C Use of serratia marcesens bacterial vaccine for preparing drug for treating lung fibrosis |
| 05/13/2009 | CN100486587C Clarithromycin liposome microsphere injection and its preparation method |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486563C Medicine composition for treating upper respiratory tract infection and its preparation process |
| 05/12/2009 | US7531651 e.g. 4-({[({[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}amino)carbonyl]amino}methyl)benzamide benzenesulfonate dihydrate; chemokine (C-C motif) receptor antagonist; antiinflammatory agent; asthma, rhinitis |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531556 Compositions useful as inhibitors of rock and other protein kinases |
| 05/12/2009 | US7531547 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531528 mixture of aqueous carrier liquid containing dissolved glucocorticoid and 3-oxoandrostane carbothioic coompound |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | CA2387398C Novel combination of loteprednol and antihistamines |
| 05/12/2009 | CA2377301C Controlled release and taste masking oral pharmaceutical compositions |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2341891C The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
| 05/12/2009 | CA2335353C Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/12/2009 | CA2322027C Use of macrolide compounds for the treatment of ards |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/07/2009 | WO2009058216A1 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 05/07/2009 | WO2009058076A1 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009056509A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
| 05/07/2009 | WO2009056292A1 Osmolyte-containing preparation for use in case of dry mucous membranes |
| 05/07/2009 | WO2009055864A1 Methods and compositions for regulating airway tissue remodelling |
| 05/07/2009 | WO2009055857A1 Calcium-rich alkaline powder produced from processed molluse shells |
| 05/07/2009 | WO2009033745A3 Use of a peptide as a therapeutic agent |
| 05/07/2009 | WO2008155035A3 Oxazolidinones for the treatment and prophylaxis of sepsis |
| 05/07/2009 | WO2008124128A3 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118369 Use of CIS-9, Trans-11 Isomer of Conjugated Lineoleic Acid |